A Phase II Study of the Safety and Efficacy of a Novel Oral fXa Inhibitor (LY517717) for the Prevention of Venous Thromboembolism Following TKR or THR.
Autor: | Agnelli, Giancarlo *, Haas, Sylvia K. *, Krueger, Kathryn A. *, Bedding, Alun W. *, Brandt, John T. |
---|---|
Zdroj: | In Blood 16 November 2005 106(11):278-278 |
Databáze: | ScienceDirect |
Externí odkaz: |